Evidence that the hypotensive effect of WAY 100635, a 5-HT1A receptor antagonist, is related to vascular alpha 1-adrenoceptor blockade in the adult rat.

1. The effect of WAY100635 (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride), a 5-HT1A receptor antagonist, on cardiovascular function was studied. 2. The i.v. injection of WAY100635 dose-dependently decreased blood pressure in anaesthetized rats; while in pithed rats WAY100635 (1 mg kg(-1)) displaced the phenylephrine pressor effect. 3. WAY100635 antagonized phenylephrine-induced contraction in rabbit and rat aorta (pA2 of 6.88 and 7.93 and Schild slopes of -0.83 and -1.21, respectively); while in rat caudal artery pK(B) was 7.45 and the Schild slope of -0.56, suggesting a complex interaction in this vessel. 4. The results show that WAY100635 induced hypotension in the anaesthetized rat and suggest that this effect could be partially explained by antagonism of vascular alpha1-adrenoceptors.

[1]  J. Gillespie,et al.  A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. , 1967, British journal of pharmacology and chemotherapy.

[2]  W. Lovenberg,et al.  Review of the Role of the Central Serotonergic Neuronal System in Blood Pressure Regulation , 1980, Hypertension.

[3]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[4]  J. Leysen,et al.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. , 1985, Molecular pharmacology.

[5]  Terrence P. Kenakin,et al.  A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .

[6]  H. Schmitt,et al.  Comparison of effects of some 5-HT1 agonists on blood pressure and heart rate of normotensive anaesthetized rats. , 1987, European journal of pharmacology.

[7]  D. Middlemiss,et al.  Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological Analysis , 1987, Journal of cardiovascular pharmacology.

[8]  G. Higgins,et al.  Cardiovascular effects of 5-HT1A receptor agonists injected into the dorsal raphe nucleus of conscious rats. , 1990, European journal of pharmacology.

[9]  E. Singer,et al.  Hypotensive effects of 8‐hydroxy‐2‐(di‐n‐propylamino)tetralin and 5‐methylurapidil following stereotaxic microinjection into the ventral medulla of the rat , 1990, British journal of pharmacology.

[10]  R. Mccall,et al.  Studies on the site and mechanism of the sympatholytic action of 8-OH DPAT , 1990, Brain Research.

[11]  M. van den Buuse,et al.  Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats. , 1992, European journal of pharmacology.

[12]  I A Cliffe,et al.  A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. , 1995, European journal of pharmacology.

[13]  A. Ford,et al.  SDZ NVI 085, an alpha 1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties. , 1996, European journal of pharmacology.

[14]  B. Jacobs,et al.  WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. , 1996, The Journal of pharmacology and experimental therapeutics.

[15]  M. Langlois,et al.  Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses. , 1998, European journal of pharmacology.

[16]  M. Piascik,et al.  Expression of multiple alpha1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. , 1999, The Journal of pharmacology and experimental therapeutics.

[17]  A. Cilia,et al.  Effect of several 5-hydroxytryptamine(1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635. , 1999, Journal of Pharmacology and Experimental Therapeutics.

[18]  E. Calama,et al.  Characterization of mechanisms involved in presynaptic inhibition of sympathetic pressor effects induced by some 5-HT1 receptor antagonists. , 2000, Journal of autonomic pharmacology.

[19]  O. Yildiz,et al.  Phenylephrine precontraction increases the sensitivity of rabbit femoral artery to serotonin by enabling 5-HT1-like receptors. , 2000, Journal of cardiovascular pharmacology.

[20]  R. Villalobos-Molina,et al.  The alpha-adrenoceptor antagonist, zolertine, inhibits alpha1D- and alpha1A-adrenoceptor-mediated vasoconstriction in vitro. , 2000, Journal of autonomic pharmacology.

[21]  W. Koek,et al.  The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors. , 2000, European journal of pharmacology.

[22]  A. Ramage,et al.  The role of α1‐adrenoceptors and 5‐HT1A receptors in the control of the micturition reflex in male anaesthetized rats , 2001, British journal of pharmacology.

[23]  R. Villalobos-Molina,et al.  The Hypotensive Effect of BMY 7378 Is Antagonized by a Silent 5-HT1A Receptor Antagonist , 2001 .

[24]  G. Milligan,et al.  Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: applications to the detection and analysis of inverse agonists and low-efficacy partial agonists. , 2002, Molecular pharmacology.